{
  "meta": {
    "title": "00281_Mid_Day_Module_Medicine-2",
    "url": "https://brainandscalpel.vercel.app/00281-mid-day-module-medicine-2-948c7d34.html",
    "scrapedAt": "2025-11-29T18:15:04.865Z"
  },
  "questions": [
    {
      "id": 11605,
      "choices": [
        {
          "id": 46386,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 3, 4</span></p>"
        },
        {
          "id": 46387,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 3</span></p>"
        },
        {
          "id": 46388,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2</span></p>"
        },
        {
          "id": 46389,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Chronic HBV infection would be consistent with which of the following serology? </span><span style=\"font-size:11pt;\">(</span><span style=\"font-size:12.0pt;\">INICET MAY 2022)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">HBsAg</span></li><li><span style=\"font-size:12.0pt;\">Anti-HBsAg</span></li><li><span style=\"font-size:12.0pt;\">Anti-HBcAg</span></li><li><span style=\"font-size:12.0pt;\">HBV DNA</span></li></ol>",
      "unique_key": "Q4311905",
      "question_audio": null,
      "question_video": null,
      "map_id": 34966099,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>A) 1, 3, 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Anti-HBs (Hepatitis B surface antibody)</strong>: This antibody appears after the infection has been cleared or following successful vaccination. It indicates immunity to HBV. In chronic HBV infection, this antibody is not present since the surface antigen is still active.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Chronic hepatitis B virus (HBV) infection is defined by the persistence of the surface antigen (HBsAg) for more than six months. The presence of HBsAg indicates an active HBV infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Serological markers:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. HBsAg (Hepatitis B surface antigen)</strong>: This antigen indicates that the person is infectious. It is found in the blood during acute and chronic HBV infection. The presence of HBsAg for more than six months defines chronic HBV infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>3. Anti-HBc (Hepatitis B core antibody)</strong>: This antibody indicates previous or ongoing infection with HBV. In chronic infection, the IgG fraction of anti-HBc is usually present.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>4. HBV DNA</strong>: The presence of HBV DNA in the blood indicates active viral replication. It is usually detectable in chronic HBV infection, although the levels can vary.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Chronic HBV infection is characterized by the persistence of HBsAg, the presence of Anti-HBc, and usually detectable HBV DNA. Anti-HBs is not present in chronic HBV infection as it indicates immunity.</span></p>",
      "correct_choice_id": 46386,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11287,
      "choices": [
        {
          "id": 45114,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Low</span></span></p>"
        },
        {
          "id": 45115,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">High</span></span></p>"
        },
        {
          "id": 45116,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Moderate</span></span></p>"
        },
        {
          "id": 45117,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cannot comment without d-dimer values</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 53-year-old woman underwent hip replacement surgery. A week after the surgery, the patient developed swelling of the legs associated with pain on palpation. Her heart rate is 70 beats per min. There is no history of hemoptysis or significant weight loss. There is no previous history of pulmonary embolism. What is the risk of developing pulmonary embolism in the patient based on Well&#39;s score? (NEET PG 2020)</span></span></p>",
      "unique_key": "Q6917858",
      "question_audio": null,
      "question_video": null,
      "map_id": 34966108,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. High </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The Well&#39;s Score is a clinical tool used to estimate the probability of a pulmonary embolism (PE). The score is calculated based on various risk factors and clinical features. In this patient&#39;s case:</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Modified wells criteria: 3 + 3 + 1.5 = 7.5 (&gt;4) suggestive of high risk.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/24/screenshot-2024-07-24-113426.jpg\" style=\"height:610px; width:981px\" /></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inference:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">4: PE Likely </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&lt; 4: PE unlikely</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When assessing the risk of pulmonary embolism, especially in postoperative patients presenting with symptoms suggestive of DVT, it is essential to consider both the clinical presentation and the surgical history. The Wells score is a valuable tool in stratifying the risk and guiding further diagnostic testing and management. In this scenario, the patient falls into a high-risk category, indicating that further immediate investigation, typically with imaging like a CT pulmonary angiogram, is warranted.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference - UpToDate/Wells score</span></span></strong></p>",
      "correct_choice_id": 45115,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "CriteriaBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11780,
      "choices": [
        {
          "id": 47086,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2 and 5 only</span></p>"
        },
        {
          "id": 47087,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3, 4 and 5</span></p>"
        },
        {
          "id": 47088,
          "text": "<p><span style=\"font-size:12.0pt;\">1 and 5 only</span></p>"
        },
        {
          "id": 47089,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 3, 4 and 5 only</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following are true regarding KF ring? (INICET NOV 2020)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">1. Seen in all patients with neurological involvement</span></p><p><span style=\"font-size:12.0pt;\">2. Is pathognomonic for Wilson's disease</span></p><p><span style=\"font-size:12.0pt;\">3. Resolves with desferrioxamine</span></p><p><span style=\"font-size:12.0pt;\">4. Seen in all patients with hepatic involvement</span></p><p><span style=\"font-size:12.0pt;\">5. Seen in superior and inferior pole of Descemet's membrane</span></p>",
      "unique_key": "Q1452126",
      "question_audio": null,
      "question_video": null,
      "map_id": 34966102,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C)&nbsp;1 and 5 only.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Statement 1</strong>: The Kayser-Fleischer ring is frequently seen in patients with neurological involvement due to Wilsonâ€™s disease, but it may not be present in all cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Statement 5</strong>: The Kayser-Fleischer ring is a copper deposit seen at the superior and inferior poles of the corneal Descemet's membrane.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Statement 2</strong>: While the KF ring is highly suggestive of Wilson's disease, it is not solely pathognomonic because it can appear in other chronic cholestatic liver conditions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Statement 3</strong>: Desferrioxamine is used for iron chelation and is not effective for copper removal in Wilson's disease. Treatment for copper overload involves agents like penicillamine or trientine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Statement 4</strong>: Not all patients with hepatic involvement due to Wilson's disease will have visible KF rings, as their presence correlates more strongly with the duration and severity of copper accumulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">KF can be seen in disorders causing chronic cholestasis. Seen in ~99% of patients with neuro wilson's, 44-60% with hepatic involvement.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Desferioxamine is chelating agent in iron toxicity.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison/Liver/Wilsons/Chap 344</strong></span></p>",
      "correct_choice_id": 47088,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11251,
      "choices": [
        {
          "id": 44970,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypothyroidism</span></span></p>"
        },
        {
          "id": 44971,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypothermia</span></span></p>"
        },
        {
          "id": 44972,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypocalcemia</span></span></p>"
        },
        {
          "id": 44973,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypokalemia</span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Osborn waves in ECG are seen in: (NEET PG 2019)</span></span></p>",
      "unique_key": "Q3955187",
      "question_audio": null,
      "question_video": null,
      "map_id": 34966107,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Hypothermia</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Osborn waves, also known as J-waves, are characteristic findings on an ECG that are typically associated with hypothermia. These waves appear as a positive deflection at the J point (the junction between the end of the QRS complex and the beginning of the ST segment) and are most evident in moderate to severe cases of hypothermia. The appearance of Osborn waves is thought to be caused by a disparity in the action potential durations between the epicardial and endocardial surfaces of the heart during ventricular repolarization.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Hypothyroidism:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This condition does not typically cause Osborn waves. Instead, hypothyroidism can lead to other ECG changes such as bradycardia, low voltage, and possibly prolonged QT interval.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Hypocalcemia:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This typically leads to a prolonged QT interval but does not cause Osborn waves.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Hypokalemia:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While hypokalemia can cause significant ECG changes, including U waves, flattened T waves, and ST depression, it is not associated with Osborn waves.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/18/picture3_XRys82B.jpg\" style=\"height:288px; width:400px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">J-wave or Osborn wave is seen in cases of&nbsp;</span></span><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">moderate or severe hypothermia&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">due to&nbsp;</span></span><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">increase in the epicardial potassium current&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">relative to that of endocardium during ventricular repolarization.</span></span></p>",
      "correct_choice_id": 44971,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11903,
      "choices": [
        {
          "id": 47577,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amlodipine</span></span></p>"
        },
        {
          "id": 47578,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Telmisartan</span></span></p>"
        },
        {
          "id": 47579,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metoprolol</span></span></p>"
        },
        {
          "id": 47580,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Olmesartan</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A hypertensive patient who is on losartan develops an HbA1c level of 8.1%. Which of the following drugs would you replace losartan with? (INICET NOV 2022)</span></span></span></p>",
      "unique_key": "Q1632809",
      "question_audio": null,
      "question_video": null,
      "map_id": 34966098,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Telmisartan</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Telmisartan is the appropriate choice for a hypertensive patient with an elevated HbA1c level (8.1%), indicating poorly controlled diabetes. Telmisartan, an angiotensin II receptor blocker (ARB), has unique properties among ARBs due to its partial agonistic activity on peroxisome proliferator-activated receptor-gamma (PPAR-gamma). PPAR-gamma agonists can improve insulin sensitivity and have beneficial effects on glycemic control. This makes Telmisartan particularly useful for patients managing both hypertension and diabetes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Amlodipine:</span></strong><span style=\"font-size:12.0pt\"> Amlodipine is a calcium channel blocker used for hypertension. It does not have the beneficial effects on glycemic control seen with Telmisartan and would not be the preferred choice in a patient with elevated HbA1c.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Metoprolol:</span></strong><span style=\"font-size:12.0pt\"> Metoprolol is a beta-blocker. While effective for hypertension, beta-blockers can potentially worsen glycemic control and are not ideal for patients with diabetes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Olmesartan:</span></strong><span style=\"font-size:12.0pt\"> Olmesartan is another ARB, but unlike Telmisartan, it lacks PPAR-gamma agonistic activity. Thus, it does not offer the additional benefit of improving insulin sensitivity and glycemic control.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For hypertensive patients with diabetes and elevated HbA1c levels, Telmisartan is the preferred replacement for losartan due to its PPAR-gamma agonistic activity, which helps improve glycemic control.</span></span></span></p>",
      "correct_choice_id": 47578,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24772,
      "choices": [
        {
          "id": 99049,
          "text": "<p><span style=\"font-size:11.0pt;\">Anti HBs&nbsp;&nbsp;&nbsp;&nbsp;</span></p>"
        },
        {
          "id": 99050,
          "text": "<p><span style=\"font-size:11.0pt;\">Anti HBc</span></p>"
        },
        {
          "id": 99051,
          "text": "<p><span style=\"font-size:11.0pt;\">HBeAg</span></p>"
        },
        {
          "id": 99052,
          "text": "<p><span style=\"font-size:11.0pt;\">HBsAg</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A patient recovered from hepatitis B infection. Which of the following curve represents antibodies seen 4 weeks post-recovery? (INICET MAY 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/screenshot-2024-09-13-152209.png\" alt=\"\" width=\"300\" height=\"147\"></span></p>",
      "unique_key": "Q7529703",
      "question_audio": null,
      "question_video": null,
      "map_id": 34966097,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A)&nbsp;Anti HBs</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">After recovery from hepatitis B infection, the patient will have antibodies against the hepatitis B surface antigen (anti-HBS), indicating immunity. The key points related to hepatitis B infection and recovery include:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>HBsAg (Hepatitis B surface antigen):</strong> Initially present during the acute phase of infection, indicating active infection. It will eventually drop and become negative upon recovery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Anti-HBc (Hepatitis B core antibody):</strong> Initially, anti-HBc IgM is positive during the acute phase, which then transitions to anti-HBc IgG as the infection progresses. The total anti-HBc represents both IgM initially and IgG later on.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>HBeAg (Hepatitis B e antigen):</strong> Indicates active viral replication and high infectivity. It decreases as the virus is cleared.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Anti-HBs (Hepatitis B surface antibody):</strong> The protective antibody indicating recovery and immunity from hepatitis B infection. This antibody appears after the disappearance of HBsAg and is a marker of immunity post-recovery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Anti HBc</strong>: Anti-HBc indicates past or current infection with hepatitis B. Initially, IgM anti-HBc is present during the acute infection, and later, IgG anti-HBc persists. However, it does not specifically indicate recovery and immunity.</span></p><p><br><span style=\"font-size:12pt;\"><strong>Option C. HBeAg</strong>: HBeAg is a marker of active viral replication and high infectivity. It is present during the active infection phase and decreases as the infection resolves.</span></p><p><br><span style=\"font-size:12pt;\"><strong>Option D. HBsAg:</strong> HBsAg indicates active hepatitis B infection. It is present during the acute phase of infection and disappears upon recovery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Anti-HBs antibodies indicate recovery and immunity from hepatitis B infection. This is the only protective antibody that signifies the patient has successfully recovered from the infection and has developed immunity.</span></p>",
      "correct_choice_id": 99049,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55350,
      "choices": [
        {
          "id": 220861,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">15:2</span></span></p>"
        },
        {
          "id": 220862,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">30:2</span></span></p>"
        },
        {
          "id": 220863,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">3:1</span></span></p>"
        },
        {
          "id": 220864,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">3:2</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">52-year-old man collapses and you are giving CPR with your friend. What is the ratio of chest compressions to rescue breaths? (FMGE JULY 2024)</span></span></p>",
      "unique_key": "Q5695506",
      "question_audio": null,
      "question_video": null,
      "map_id": 34966091,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. B) 30:2</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">In adult life support, the standard ratio of chest compressions to rescue breaths is 30:2, regardless of the number of rescuers. This ratio ensures that there is an adequate number of compressions to maintain circulation, while also providing necessary breaths to maintain oxygenation</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">In pediatric Advanced Cardiovascular Life Support (ACLS), the ratio can vary depending on the number of rescuers. If there is only one rescuer, the ratio remains 30:2. However, if there are two rescuers, the ratio can change to 15:2. </span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">For neonates, the ratio is different, typically 3:1.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">In adult CPR, the ratio of chest compressions to rescue breaths is always 30:2, regardless of the number of rescuers.</span></span></p>",
      "correct_choice_id": 220862,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 92145,
      "choices": [
        {
          "id": 366896,
          "text": "<p><span style=\"font-size:14.0pt;\">Chronic bacterial prostatitis</span></p>"
        },
        {
          "id": 366897,
          "text": "<p><span style=\"font-size:14.0pt;\">Acute bacterial prostatitis</span></p>"
        },
        {
          "id": 366898,
          "text": "<p><span style=\"font-size:14.0pt;\">Chronic Granulomatous prostatitis</span></p>"
        },
        {
          "id": 366899,
          "text": "<p><span style=\"font-size:14.0pt;\">Sterile pyuria</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 58-year-old male presents with complaints of burning micturition and increased frequency. Prostatic examination is normal. Urinalysis shows &gt;50 pus cells per high power field, but urine culture shows no growth. What is the most likely diagnosis? (INICET MAY 2025)</span></p>",
      "unique_key": "Q7642177",
      "question_audio": null,
      "question_video": null,
      "map_id": 34966093,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Chronic bacterial prostatitis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This presentation is classic for chronic bacterial prostatitis. The patient has lower urinary tract symptoms (LUTS) including dysuria and urinary frequency, with significant pyuria (&gt;50 WBCs/hpf) but negative routine urine culture.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The key feature of chronic bacterial prostatitis is that routine voided bladder cultures (VB1 and VB2) are typically negative, while only cultures of expressed prostatic secretions (EPS) after prostatic massage or urine voided after prostatic massage (VB3) would be positive.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The prostatic examination can be normal in many cases of chronic bacterial prostatitis, which was previously also called chronic pelvic pain syndrome. The significant symptomatology cannot be ignored and simply attributed to sterile pyuria in a symptomatic patient.</span></p><p><br><br><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Acute bacterial prostatitis:</strong> This is ruled out because in acute bacterial prostatitis, the prostate would be exquisitely tender to touch. Prostatic massage is actually contraindicated in acute cases as it can cause pain and shock. The normal prostatic examination effectively excludes this diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Chronic Granulomatous prostatitis:</strong> This rare condition presents with multiple small granulomas giving a nodular texture to the prostate. The patient would have palpable nodules on prostatic examination that could mimic cancer. A normal prostatic examination rules out this diagnosis, and prostatic biopsy would be required for confirmation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Sterile pyuria:</strong> While the routine urine culture is negative, the significant symptomatology in this 58-year-old male with classic LUTS cannot be dismissed as simple sterile pyuria. The symptoms must be evaluated and cannot be ignored, especially given the clinical presentation consistent with chronic bacterial prostatitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Chronic bacterial prostatitis presents with LUTS and pyuria but negative routine urine cultures; only EPS cultures or post-massage urine cultures are positive.</span><br><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Classification of Prostatitis:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_cu6Nx1K.png\" width=\"1236\" height=\"589\"></strong></span></p>",
      "correct_choice_id": 366896,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92145/Ini_Cet_May_2025_Medicine_Q_-_6new.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92145/Ini_Cet_May_2025_Medicine_Q_-_6new.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11577,
      "choices": [
        {
          "id": 46274,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Calcium channel blocker </span></span></span></p>"
        },
        {
          "id": 46275,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Beta blocker </span></span></span></p>"
        },
        {
          "id": 46276,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Alpha blocker </span></span></span></p>"
        },
        {
          "id": 46277,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Diuretic</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For the diagnosis of resistant hypertension, the patient should have uncontrolled hypertension despite taking three antihypertensive drugs. This should include at least one? (INICET MAY 2021)</span></span></p>",
      "unique_key": "Q3464222",
      "question_audio": null,
      "question_video": null,
      "map_id": 34966101,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">D) Diuretic</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Resistant hypertension is defined as blood pressure that remains above the target levels despite the use of three antihypertensive agents of different classes, one of which should be a diuretic. This is because diuretics, typically thiazide diuretics, help to reduce blood volume and are effective in lowering blood pressure. Including a diuretic ensures optimal blood pressure control.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Calcium channel blockers</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Calcium channel blockers are used but are not specifically required for the diagnosis of resistant hypertension.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Beta blockers</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Beta blockers are also commonly used but not specifically required for the definition. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Alpha blockers</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Alpha blockers may be used as part of the treatment regimen but are not specifically required.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The diagnostic criteria for resistant hypertension include having blood pressure above target despite taking three drugs, one of which must be a diuretic, OR having controlled blood pressure with four or more drugs. Typically, a thiazide diuretic is used in the setting of hypertension.</span></span></span></p>",
      "correct_choice_id": 46277,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47526,
      "choices": [
        {
          "id": 189715,
          "text": "<p><span style=\"font-size:12.0pt;\">Lymphocytes</span></p>"
        },
        {
          "id": 189716,
          "text": "<p><span style=\"font-size:12.0pt;\">Monocytes</span></p>"
        },
        {
          "id": 189717,
          "text": "<p><span style=\"font-size:12.0pt;\">Plasma cells</span></p>"
        },
        {
          "id": 189718,
          "text": "<p><span style=\"font-size:12.0pt;\">Histiocytes</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 70-year-old man presented with back pain for the past 3 months. On examination, he has pallor, and gamma globulins are elevated. LFT is normal. X-ray spine shows multiple lytic lesions. Which of the following cells are involved in the pathogenesis of this patient's condition?</span></p>",
      "unique_key": "Q7605641",
      "question_audio": null,
      "question_video": null,
      "map_id": 34966089,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Plasma cells</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's presentation is consistent with <strong>multiple myeloma</strong>, a plasma cell neoplasm. Key diagnostic features include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Back pain:&nbsp;</strong>Common in multiple myeloma due to bone involvement.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Pallor:&nbsp;</strong>Indicates anemia, a common finding in multiple myeloma.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Elevated gamma globulins:&nbsp;</strong>Suggests a monoclonal protein spike (M spike) on serum protein electrophoresis.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Multiple lytic lesions on X-ray:&nbsp;</strong>Classic radiographic finding in multiple myeloma due to bone destruction.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In multiple myeloma, malignant clonal <strong>plasma cells</strong> proliferate in the bone marrow, leading to the production of abnormal monoclonal immunoglobulins, bone destruction, and marrow infiltration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A, B &amp; D: </strong>Not primarily involved in multiple myeloma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Multiple myeloma is a plasma cell neoplasm characterized by anemia, elevated gamma globulins, and lytic bone lesions, with plasma cells being the key pathological cells involved.</span></p>",
      "correct_choice_id": 189717,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73066,
      "choices": [
        {
          "id": 291229,
          "text": "<p><span style=\"font-size:16px;\">Gradual prolongation of PR interval followed by a non-conducted P wave</span></p>"
        },
        {
          "id": 291230,
          "text": "<p><span style=\"font-size:16px;\">Prolonged PR interval, and each P wave is followed by a QRS complex</span></p>"
        },
        {
          "id": 291231,
          "text": "<p><span style=\"font-size:16px;\">Presence of atrioventricular dissociation</span></p>"
        },
        {
          "id": 291232,
          "text": "<p><span style=\"font-size:16px;\">Normal PR interval followed by a non-conducted P wave</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Which of the following is true regarding first-degree AV block? (FMGE JAN 2025)</span></p>",
      "unique_key": "Q8495685",
      "question_audio": null,
      "question_video": null,
      "map_id": 34966092,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) Prolonged PR interval, and each P wave is followed by a QRS complex</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">First-degree <strong>AV block</strong> is characterized by <strong>prolongation of the PR interval</strong> (<strong>&gt;0.2 seconds or &gt;200 milliseconds</strong>) with <strong>each P wave being followed by a QRS complex</strong>. This represents a delay in conduction through the <strong>AV node</strong>, but <strong>every atrial impulse still successfully conducts to the ventricles</strong>. On <strong>ECG</strong>, this appears as <strong>more than five small boxes</strong> between the <strong>P wave and QRS complex</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Gradual prolongation of PR interval followed by a non-conducted P wave:&nbsp;</strong>Incorrect</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">Describes Mobitz</span></li><li><span style=\"font-size:16px;\"><strong>type I (Wenckebach) second-degree AV block</strong>, where <strong>PR lengthens progressively until a P wave fails to conduct</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Presence of atrioventricular dissociation:</strong> Incorrect</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\"><strong>Seen in third-degree (complete) heart block</strong>, where the <strong>atria and ventricles beat independently</strong></span></li><li><span style=\"font-size:16px;\">P waves and QRS complexes have no relation to each other</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Normal PR interval followed by a non-conducted P wave:</strong> Incorrect</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">Describes Mobitz type II second-degree AV block, where PR remains constant but occasional P waves fail to conduct</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>First-degree AV block</strong> is characterized by a <strong>prolonged PR interval (&gt;0.2 seconds)</strong> with <strong>1:1 conduction</strong>, where <strong>each P wave is followed by a QRS complex</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_dVGBeYB.png\" width=\"566\" height=\"334\"></span></p>",
      "correct_choice_id": 291230,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/73066/FMGE_Jan_2025_Medicine_Q_-_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "CriteriaBased",
        "DiagnosisBased",
        "Factual",
        "FMGE"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/73066/FMGE_Jan_2025_Medicine_Q_-_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54274,
      "choices": [
        {
          "id": 216565,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dapagliflozin</span></span></p>"
        },
        {
          "id": 216566,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glimepiride</span></span></p>"
        },
        {
          "id": 216567,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metformin</span></span></p>"
        },
        {
          "id": 216568,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sitagliptin</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 30-year-old patient with heart failure and poorly controlled type 2 diabetes (HbA1c of 7.8%) presents with progressive dyspnea. Which is the preferred antidiabetic drug?</span></span></span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q8718982",
      "question_audio": null,
      "question_video": null,
      "map_id": 34966095,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Dapagliflozin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dapagliflozin is a sodium-glucose co-transporter-2 (SGLT2) inhibitor that has shown significant benefits in patients with heart failure, particularly heart failure with reduced ejection fraction (HFrEF). SGLT2 inhibitors, including dapagliflozin and empagliflozin, have been demonstrated to improve survival, reduce heart failure hospitalizations, and delay the progression of heart failure. These benefits make SGLT2 inhibitors the preferred choice for patients with both type 2 diabetes and heart failure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Four Pillars in the Management of HFrEF (Heart Failure with Reduced Ejection Fraction):</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">ARNIs and ACE Inhibitors/ARBs</span></strong><span style=\"font-size:12.0pt\">:</span></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">ARNIs (e.g., Sacubitril/Valsartan) are preferred.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">ACE Inhibitors/ARBs are also used.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Beta Blockers</span></strong><span style=\"font-size:12.0pt\">:</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Metoprolol</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Bisoprolol</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Carvedilol</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">MRAs (Mineralocorticoid Receptor Antagonists)</span></strong><span style=\"font-size:12.0pt\">:</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Spironolactone</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Eplerenone</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">SGLT2 Inhibitors</span></strong><span style=\"font-size:12.0pt\">:</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Empagliflozin</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dapagliflozin</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Glimepiride:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is a sulfonylurea that primarily helps in lowering blood glucose by stimulating insulin secretion. It does not provide the cardiovascular benefits seen with SGLT2 inhibitors and can increase the risk of hypoglycemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Metformin:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> While metformin is a first-line therapy for type 2 diabetes and has some cardiovascular benefits, it is not specifically indicated for improving heart failure outcomes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Sitagliptin:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is a dipeptidyl peptidase-4 (DPP-4) inhibitor used to manage blood glucose levels. It does not provide the same level of heart failure benefit as SGLT2 inhibitors.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">For patients with type 2 diabetes and heart failure, SGLT2 inhibitors like dapagliflozin are the preferred antidiabetic medications due to their proven benefits in reducing heart failure progression, hospitalizations, and mortality.</span></span></span></p>",
      "correct_choice_id": 216565,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16293,
      "choices": [
        {
          "id": 65132,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Synchronised cardioversion</span></span></span></p>"
        },
        {
          "id": 65133,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Continue CPR</span></span></span></p>"
        },
        {
          "id": 65134,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Deliver another DC shock</span></span></span></p>"
        },
        {
          "id": 65135,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1 mg epinephrine IV</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An intern observed that a patient was unresponsive, and an ECG which was performed urgently showed an arrhythmia as below. DC shock was delivered but the arrhythmia persisted and the patient is still unresponsive. What is the next best step in the management of this patient?&nbsp;</span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">(FMGE DEC 2021)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/30/screenshot-2024-09-30-125438.png\" style=\"height:45px; width:300px\" /></span></span></p>",
      "unique_key": "Q7997184",
      "question_audio": null,
      "question_video": null,
      "map_id": 34966152,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Continue CPR</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">After detecting ventricular fibrillation (VF) and delivering a DC shock, continue CPR for at least 2 minutes before rechecking the rhythm. Avoid the immediate temptation to reassess the rhythm right after the shock. After 2 minutes of CPR, check the rhythm again. If it remains shockable (e.g., VF or VT), administer another shock. If the rhythm is non-shockable, continue CPR for another 2 minutes. Repeat this process as necessary, depending on the rhythm assessment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Synchronised cardioversion</span></strong><span style=\"font-size:12.0pt\">: This is used for treating hemodynamically unstable tachyarrhythmias with a pulse, not for cardiac arrest.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Deliver another DC shock</span></strong><span style=\"font-size:12.0pt\">: This can be considered, but only after continuing CPR for a specific period and following advanced cardiac life support (ACLS) protocols.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. 1 mg epinephrine IV</span></strong><span style=\"font-size:12.0pt\">: Epinephrine is administered after continuing CPR, usually every 3-5 minutes during cardiac arrest management according to ACLS guidelines, but the immediate next step after the initial shock is to continue CPR.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">After delivering an initial DC shock in a cardiac arrest situation, the next step is to continue CPR to maintain circulation until further advanced interventions can be administered.</span></span></span></p>",
      "correct_choice_id": 65133,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 84332,
      "choices": [
        {
          "id": 335900,
          "text": "<p>Inferior frontal gyrus of the left hemisphere</p>"
        },
        {
          "id": 335901,
          "text": "<p>Inferior frontal gyrus of the right hemisphere</p>"
        },
        {
          "id": 335902,
          "text": "<p>Superior temporal gyrus of the left hemisphere</p>"
        },
        {
          "id": 335903,
          "text": "<p>Superior temporal gyrus of the right hemisphere</p>"
        }
      ],
      "text": "<p>A right-handed individual exhibits non-fluent aphasia with intact comprehension. Which of the following brain regions is most likely affected? (NEET PG 2015)</p>",
      "unique_key": "Q2167930",
      "question_audio": null,
      "question_video": null,
      "map_id": 34966103,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><strong>Correct Answer: A. Inferior frontal gyrus of the left hemisphere</strong></p><p>&nbsp;</p><p><strong>Explanation:</strong></p><p>&nbsp;</p><p>This patient has non-fluent aphasia with intact comprehension, which is characteristic of Broca's aphasia. Broca's aphasia results from damage to the inferior frontal gyrus (Broca's area) in the dominant hemisphere, which is the left hemisphere in right-handed individuals. This area is supplied by the superior division of the middle cerebral artery. In Broca's aphasia, speech production is impaired (non-fluent) while comprehension remains relatively intact.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option B. Inferior frontal gyrus of the right hemisphere:</strong> In right-handed individuals, language functions are usually lateralized to the left hemisphere. The right inferior frontal gyrus is not primarily responsible for language production, so damage here would not typically cause non-fluent aphasia.</p><p>&nbsp;</p><p><strong>Option C. Superior temporal gyrus of the left hemisphere:</strong> Damage to this area (Wernicke's area) causes a different type of aphasia characterized by fluent speech with poor comprehension (Wernicke's aphasia), which is the opposite of what the patient exhibits.</p><p>&nbsp;</p><p><strong>Option D. Superior temporal gyrus of the right hemisphere:</strong> Similar to option B, the right hemisphere in right-handed individuals is not dominant for language functions. Damage to this area would not typically cause aphasia.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong>&nbsp;</p><p>&nbsp;</p><p>Non-fluent aphasia with preserved comprehension (Broca's aphasia) results from damage to the inferior frontal gyrus (Broca's area) in the dominant hemisphere, which is the left hemisphere in most right-handed individuals.</p>",
      "correct_choice_id": 335900,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74880,
      "choices": [
        {
          "id": 298421,
          "text": "<p><span style=\"font-size:16px;\">60â€“90 mL/min/1.73mÂ²</span></p>"
        },
        {
          "id": 298422,
          "text": "<p><span style=\"font-size:16px;\">15â€“30 mL/min/1.73mÂ²</span></p>"
        },
        {
          "id": 298423,
          "text": "<p><span style=\"font-size:16px;\">45â€“59 mL/min/1.73mÂ²</span></p>"
        },
        {
          "id": 298424,
          "text": "<p><span style=\"font-size:16px;\">30â€“44 mL/min/1.73mÂ²</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">According to KDIGO staging of chronic kidney disease (CKD), what is the GFR range for stage 3b? (INICET NOV 2024)</span></p>",
      "unique_key": "Q6481712",
      "question_audio": null,
      "question_video": null,
      "map_id": 34966094,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D) 30â€“44 mL/min/1.73mÂ²</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Stage 3b CKD is defined by a GFR range of 30â€“44 mL/min/1.73mÂ². CKD stage 3 is divided into two subcategories:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Stage 3a: GFR 45â€“59 mL/min/1.73mÂ²</span></li><li><span style=\"font-size:16px;\">Stage 3b: GFR 30â€“44 mL/min/1.73mÂ²</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">GFR ranges for CKD staging:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Stage 1: &gt;90 mL/min/1.73mÂ²</span></li><li><span style=\"font-size:16px;\">Stage 2: 60â€“89 mL/min/1.73mÂ²</span></li><li><span style=\"font-size:16px;\">Stage 3a: 45â€“59 mL/min/1.73mÂ²</span></li><li><span style=\"font-size:16px;\">Stage 3b: 30â€“44 mL/min/1.73mÂ²</span></li><li><span style=\"font-size:16px;\">Stage 4: 15â€“29 mL/min/1.73mÂ²</span></li><li><span style=\"font-size:16px;\">Stage 5: &lt;15 mL/min/1.73mÂ²</span></li></ul>",
      "correct_choice_id": 298424,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50958,
      "choices": [
        {
          "id": 203373,
          "text": "<p><span style=\"font-size:12.0pt;\">Diet, Exercise, Lifestyle modification + Metoprolol&nbsp;</span></p>"
        },
        {
          "id": 203374,
          "text": "<p><span style=\"font-size:12.0pt;\">Diet, Exercise, Lifestyle modification&nbsp;</span></p>"
        },
        {
          "id": 203375,
          "text": "<p><span style=\"font-size:12.0pt;\">Diet + Prazosin&nbsp;</span></p>"
        },
        {
          "id": 203376,
          "text": "<p><span style=\"font-size:12.0pt;\">Diet, Exercise, Lifestyle modification + Amlodipine&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old man with a known history of diabetes mellitus presents with a BP of 150/90 and dizziness. What is the best way to manage this patient? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">INICET Nov 2023)</span></p>",
      "unique_key": "Q9820360",
      "question_audio": null,
      "question_video": null,
      "map_id": 34966096,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D)&nbsp;Diet, Exercise, Lifestyle modification + Amlodipine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For a 60-year-old patient with diabetes and hypertension (BP 150/90 mmHg), it is critical to start pharmacological therapy along with lifestyle modifications to reduce cardiovascular risk. Current guidelines, including the 2023 European Society of Cardiology (ESC) guidelines, recommend initiating antihypertensive therapy in such patients due to the high risk of cardiovascular events. Amlodipine, a calcium channel blocker, is an appropriate choice for initial antihypertensive therapy in diabetic patients. It effectively lowers blood pressure and is well-tolerated, without negatively impacting glycemic control. Ideally, an ACE inhibitor or ARB would be preferred, but if not available, a calcium channel blocker like amlodipine is a suitable alternative.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Diet, Exercise, Lifestyle modification + Metoprolol</strong>: Metoprolol, a beta-blocker, is not first-line therapy for hypertension unless there is a specific indication such as coronary artery disease, heart failure, or angina. Beta-blockers are not the preferred initial treatment for hypertensive diabetics.</span></p><p><span style=\"font-size:10pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Diet, Exercise, Lifestyle modification:&nbsp;</strong>While lifestyle modifications are important, they are insufficient alone for managing hypertension in a diabetic patient, who is at high cardiovascular risk.</span></p><p><span style=\"font-size:10pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Diet + Prazosin:&nbsp;</strong>Prazosin, an alpha-blocker, is not typically used as first-line therapy for hypertension. It may be used in patients with benign prostatic hyperplasia (BPH) but offers no additional advantage in this context and may cause orthostatic hypotension, worsening dizziness.</span></p><p><span style=\"font-size:10pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For hypertensive diabetic patients, it is essential to start pharmacological therapy along with lifestyle modifications to reduce cardiovascular risk. Amlodipine is an appropriate choice for initial therapy in this context.</span></p>",
      "correct_choice_id": 203376,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11837,
      "choices": [
        {
          "id": 47314,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">4 and 5</span></span></p>"
        },
        {
          "id": 47315,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">3 and 5</span></span></p>"
        },
        {
          "id": 47316,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1 and 2</span></span></p>"
        },
        {
          "id": 47317,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2 only</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 62-year-old male patient with heart failure is scheduled for a heart transplant. His renal function test is deranged, and hemoglobin is 6 g/dL. The physician ordered 2 units of whole blood. Four hours after transfusion, he developed severe respiratory distress. On examination, he is hypoxemic, has tachycardia, and his mean arterial pressure is elevated. Which of the following are the best investigations for the above scenario? (INICET NOV 2021)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Chest X-ray</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Brain natriuretic peptide (BNP) level</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Absolute neutrophil count</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Leucocyte antibodies</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Platelets</span></span></span></li>\r\n</ol>",
      "unique_key": "Q6030204",
      "question_audio": null,
      "question_video": null,
      "map_id": 34966100,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) 1 and 2</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient presents with signs and symptoms indicative of transfusion-associated circulatory overload (TACO), which includes elevated mean arterial pressure, hypoxemia, and respiratory distress following a blood transfusion. TACO occurs due to fluid overload from the transfusion, leading to pulmonary edema and increased cardiac filling pressures.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">1. Chest X-ray</span></strong><span style=\"font-size:12.0pt\">: This imaging is crucial as it can reveal bilateral infiltrates indicative of pulmonary edema, a hallmark of TACO. It helps to differentiate between TACO and other causes of respiratory distress post-transfusion.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">2. Brain Natriuretic Peptide (BNP) Level</span></strong><span style=\"font-size:12.0pt\">: BNP is a cardiac biomarker that is elevated in conditions of increased cardiac pressure and volume overload, such as TACO. Elevated BNP levels would support the diagnosis of TACO, whereas BNP levels would not be elevated in transfusion-related acute lung injury (TRALI), another potential complication post-transfusion that presents with respiratory distress but usually with hypotension.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">3. </span></strong><span style=\"font-size:12.0pt\"><strong>Absolute neutrophil count </strong>and <strong>5.</strong> <strong>platelets </strong>are not specific for diagnosing TACO or TRALI. These parameters do not provide information on fluid overload or cardiac stress.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">4. </span></strong><span style=\"font-size:12.0pt\"><strong>Leucocyte antibodies </strong>are not directly relevant to the diagnosis of TACO. Leucocyte antibodies might be involved in TRALI, but not TACO.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For a patient with suspected transfusion-associated circulatory overload (TACO), the best investigations are a chest X-ray to detect pulmonary edema and BNP levels to assess cardiac stress and fluid overload</span></span></span></p>",
      "correct_choice_id": 47316,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11356,
      "choices": [
        {
          "id": 45390,
          "text": "<p><span style=\"font-size:12.0pt;\">Prior Infective Endocarditis</span></p>"
        },
        {
          "id": 45391,
          "text": "<p><span style=\"font-size:12.0pt;\">Atrial Septal Defect</span></p>"
        },
        {
          "id": 45392,
          "text": "<p><span style=\"font-size:12.0pt;\">Unrepaired Cyanotic Congenital Heart Disease</span></p>"
        },
        {
          "id": 45393,
          "text": "<p><span style=\"font-size:12.0pt;\">Cardiac transplant with valvulopathy</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which among the following according to the latest guidelines is NOT an indication to IE prophylaxis? (Neet pg 2022)</span></p>",
      "unique_key": "Q9273435",
      "question_audio": null,
      "question_video": null,
      "map_id": 34966110,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B.</strong> <strong>Atrial Septal Defect</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">According to the latest guidelines, there are specific indications for infective endocarditis (IE) prophylaxis to prevent infection in high-risk patients. These indications include:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Prior Infective Endocarditis</strong>: Patients with a history of infective endocarditis are at increased risk for recurrence and hence, are recommended for prophylaxis.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Prosthetic Valves</strong>: Patients with prosthetic heart valves, especially mechanical valves, are susceptible to infections and require prophylaxis.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Cardiac Transplant with Valvulopathy</strong>: Those who have undergone cardiac transplant and have developed valvulopathy are also indicated for IE prophylaxis.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Congenital Heart Disease</strong>: This includes any unrepaired cyanotic congenital heart disease, repaired congenital heart disease with prosthetic material for the first six months post-repair, or repaired congenital heart disease with residual defects.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Atrial Septal Defect (ASD)</strong> is not listed among these high-risk conditions. ASD, especially without significant gradient across the atria or significant shunting, has a very low risk of causing infective endocarditis. Therefore, ASD does not fit into the current guidelines for IE prophylaxis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Prior Infective Endocarditis:</strong> Prior infective endocarditis significantly increases the risk of recurrent infection, thus requiring IE prophylaxis as per the guidelines.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Unrepaired Cyanotic Congenital Heart Disease:</strong> Unrepaired cyanotic congenital heart disease is a high-risk condition for infective endocarditis, necessitating prophylaxis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Cardiac Transplant with Valvulopathy:</strong> Patients who have undergone a cardiac transplant and have valvulopathy are at increased risk for infection and are indicated for IE prophylaxis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Atrial Septal Defect (ASD) is not an indication for infective endocarditis prophylaxis according to the latest guidelines, whereas prior infective endocarditis, prosthetic valves, cardiac transplant with valvulopathy, and certain congenital heart diseases are key indications.</span></p>",
      "correct_choice_id": 45391,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 49314,
      "choices": [
        {
          "id": 196823,
          "text": "<p><span style=\"font-size:12.0pt;\">Hallervorden-Spatz disease</span></p>"
        },
        {
          "id": 196824,
          "text": "<p><span style=\"font-size:12.0pt;\">Hemochromatosis</span></p>"
        },
        {
          "id": 196825,
          "text": "<p><span style=\"font-size:12.0pt;\">Wilson's Disease</span></p>"
        },
        {
          "id": 196826,
          "text": "<p><span style=\"font-size:12.0pt;\">Cystic Fibrosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Neurodegeneration with iron accumulation in the basal ganglia is typically seen in: (NEET PG 2017)</span></p>",
      "unique_key": "Q1636188",
      "question_audio": null,
      "question_video": null,
      "map_id": 34966105,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><strong>Ans. A) Hallervorden-Spatz disease</strong></p><p>&nbsp;</p><p><strong>Explanation:</strong></p><p>&nbsp;</p><p>Hallervorden-Spatz disease, now officially renamed as Pantothenate Kinase-Associated Neurodegeneration (PANK), is characterized by excessive iron deposition in the basal ganglia, particularly in the globus pallidus and substantia nigra. This neurodegenerative disorder typically presents with dystonia, parkinsonism, and cognitive decline. The pathological hallmark is neurodegeneration with iron accumulation specifically in the basal ganglia regions. The characteristic \"eye of the tiger\" sign seen on MRI reflects the pattern of iron accumulation with central hyperintensity surrounded by hypointensity in the globus pallidus.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option B. Hemochromatosis -</strong> While hemochromatosis involves systemic iron overload affecting multiple organs (particularly liver, pancreas, heart, and joints), it does not typically cause significant neurodegeneration with iron accumulation in the basal ganglia. The CNS is relatively spared in this condition.</p><p>&nbsp;</p><p><strong>Option C. Wilson's Disease -</strong> This is characterized by abnormal copper metabolism and copper accumulation in various tissues including the brain, liver, and cornea. The basal ganglia are affected, but the pathology involves copper deposition, not iron accumulation. Wilson's disease can present with parkinsonism but through a different pathophysiological mechanism.</p><p>&nbsp;</p><p><strong>Option D. Cystic Fibrosis -</strong> This is a genetic disorder affecting primarily the lungs and pancreas. It has no association with iron accumulation in the basal ganglia or other brain regions.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong>&nbsp;</p><p>&nbsp;</p><p>Hallervorden-Spatz disease (PANK) is the classic example of neurodegeneration with brain iron accumulation, specifically targeting the basal ganglia and resulting in a distinctive movement disorder with both dystonic and parkinsonian features.</p>",
      "correct_choice_id": 196823,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11213,
      "choices": [
        {
          "id": 44818,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hepatitis C</span></span></span></span></p>"
        },
        {
          "id": 44819,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ovarian cancer</span></span></span></span></p>"
        },
        {
          "id": 44820,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diabetes</span></span></span></span></p>"
        },
        {
          "id": 44821,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lymphoma</span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cryoglobulinemia is associated with? (NEET PG 2018)</span></span></p>",
      "unique_key": "Q1883112",
      "question_audio": null,
      "question_video": null,
      "map_id": 34966106,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Hepatitis C</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cryoglobulinemia, a condition characterized by the presence of abnormal proteins in the blood that precipitate at cold temperatures, is most commonly associated with Hepatitis C infection. This association is due to the immune response to the virus, which can lead to the production of these abnormal proteins. Hepatitis C-related cryoglobulinemia can result in a variety of symptoms, including rash, joint pain, and kidney problems.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other causes:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Infection:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hep B, C, HIV</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Autoimmune Disease:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sjogren, SLE</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Malignancy:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MGUS, Myeloma, <em>CLL</em></span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Ovarian cancer:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">There is no established link between ovarian cancer and cryoglobulinemia. While malignancies can be associated with cryoglobulinemia, ovarian cancer is not typically among them.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Diabetes:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diabetes is not associated with cryoglobulinemia. While diabetes can cause a wide range of vascular and immunological issues, it does not directly cause the production of cryoglobulins.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Lymphoma:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While certain hematologic malignancies like multiple myeloma and chronic lymphocytic leukemia can be associated with cryoglobulinemia, lymphoma is not as commonly linked compared to Hepatitis C.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Most common cause a/w Cryoglobulinemia is hepatitis C</span></span></p>",
      "correct_choice_id": 44818,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16435,
      "choices": [
        {
          "id": 65700,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic lymphocytic leukemia</span></span></p>"
        },
        {
          "id": 65701,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic myeloid leukemia</span></span></p>"
        },
        {
          "id": 65702,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute lymphoblastic leukemia</span></span></p>"
        },
        {
          "id": 65703,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute myeloid leukemia</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 60-year-old man presents with fatigue, pallor, weight loss, and heaviness in the left hypochondrium for the past 2 months. Abdominal palpation reveals splenomegaly. His hemogram and peripheral smear results are given below. (FMGE JUNE 2022)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hemogram: Hb &ndash; 10 gm/dL, </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">WBC count &ndash; 1,65,000, </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Platelet count &ndash; 3 lakhs, </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">PS: Metamyelocytes &ndash; 15%, Promyeloblasts &ndash; 30%, Myeloblasts &ndash; 45%. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">What is the most likely diagnosis? </span></span></span></p>",
      "unique_key": "Q4507818",
      "question_audio": null,
      "question_video": null,
      "map_id": 34966153,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>D) Acute myeloid leukemia</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The presence of more than 20% blasts (myeloblasts) in the peripheral smear indicates acute myeloid leukemia (AML). AML is characterized by the rapid increase of abnormal white blood cells, which accumulate in the bone marrow and interfere with the production of normal blood cells.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Diagnostic Steps</span></strong><span style=\"font-size:12.0pt\">:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Bone Marrow Aspiration</span></strong><span style=\"font-size:12.0pt\">: This is essential to examine the types and numbers of cells in the bone marrow.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Flow Cytometry</span></strong><span style=\"font-size:12.0pt\">: Used to identify cells by their molecular markers, which is crucial for classifying the type of leukemia.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Cytogenetic Testing</span></strong><span style=\"font-size:12.0pt\">: Analyzes the chromosomes of cells from samples of bone marrow to identify genetic abnormalities associated with AML.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Chronic lymphocytic leukemia</span></strong><span style=\"font-size:12.0pt\">: Characterized by the accumulation of mature but dysfunctional lymphocytes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Chronic myeloid leukemia</span></strong><span style=\"font-size:12.0pt\">: Typically shows a lower percentage of blasts (&lt;20% &amp; in chronic cases &lt;5%) and may progress to a blast crisis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Acute lymphoblastic leukemia</span></strong><span style=\"font-size:12.0pt\">: More common in children and involves lymphoblasts.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acute myeloid leukemia is diagnosed when there is a high percentage of myeloblasts (&gt;20%) in the blood or bone marrow.</span></span></span></p>",
      "correct_choice_id": 65703,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11310,
      "choices": [
        {
          "id": 45206,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Triamterene</span></span></p>"
        },
        {
          "id": 45207,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">KCl</span></span></p>"
        },
        {
          "id": 45208,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clarithromycin</span></span></p>"
        },
        {
          "id": 45209,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atenolol</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 55-year-old man presented with cough and congestion in the chest. He is a known case of atrial fibrillation (AF) and on examination, he had an irregularly irregular pulse and ECG showed AF with a heart rate of 52/min. His current medications are KCl 10 mEq BID, Triamterene, ASA 100mg/day, Atenolol 50 mg BID, and Clarithromycin. Two months ago, his digoxin levels were 1.5 ng/mL and currently, it rose to 3.4 ng/mL. Which of the following is responsible for such an increase in digoxin levels?</span> <span style=\"font-size:12.0pt\">(NEET PG 2021)</span></span></span></p>",
      "unique_key": "Q8044888",
      "question_audio": null,
      "question_video": null,
      "map_id": 34966109,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C. Clarithromycin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient is experiencing elevated digoxin levels, which is likely due to a drug-drug interaction. Digoxin is a medication used to treat various heart conditions, including atrial fibrillation. It has a narrow therapeutic index, meaning that even small changes in its levels can lead to toxicity.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Clarithromycin is a macrolide antibiotic that inhibits the enzyme cytochrome P450 3A4 (CYP3A4). Digoxin is partially metabolized by CYP3A4. When clarithromycin inhibits this enzyme, it can lead to decreased metabolism of digoxin, resulting in elevated digoxin levels and potential toxicity. This interaction can explain the significant increase in the patient&#39;s digoxin levels from 1.5 ng/mL to 3.4 ng/mL.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Triamterene:</span></strong><span style=\"font-size:12.0pt\"> Triamterene is a potassium-sparing diuretic and does not typically interact with digoxin in a way that would cause elevated digoxin levels. It is not known to inhibit the metabolism of digoxin.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. KCl:</span></strong><span style=\"font-size:12.0pt\"> Potassium chloride (KCl) supplementation is often given to prevent hypokalemia, which can enhance the toxic effects of digoxin. However, KCl does not directly interact with digoxin to increase its serum levels. Instead, it helps mitigate digoxin toxicity by maintaining normal potassium levels.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Atenolol:</span></strong><span style=\"font-size:12.0pt\"> Atenolol is a beta-blocker and does not interact with digoxin to increase its serum levels. While it can affect heart rate, it does not interfere with the metabolism or excretion of digoxin.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clarithromycin, by inhibiting CYP3A4, can significantly elevate digoxin levels, leading to toxicity. When prescribing medications, it is essential to consider potential drug-drug interactions, especially with drugs like digoxin that have a narrow therapeutic index.</span></span></p>",
      "correct_choice_id": 45208,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20274,
      "choices": [
        {
          "id": 81057,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pseudogout</span></span></span></p>"
        },
        {
          "id": 81058,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acute gout</span></span></span></p>"
        },
        {
          "id": 81059,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Reactive arthritis</span></span></span></p>"
        },
        {
          "id": 81060,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Septic arthritis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A chronic alcoholic patient presents with acute pain and swelling of the left great toe. There is no history of trauma. Synovial fluid analysis shows raised leukocytes. Lab investigations show normal serum uric acid levels. What is the most likely diagnosis? (NEET PG 2023)</span></span></span></p>",
      "unique_key": "Q2994041",
      "question_audio": null,
      "question_video": null,
      "map_id": 34966151,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B. Acute gout</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient presents with acute pain and swelling in the left great toe, a common presentation of acute gout. Despite normal serum uric acid levels, the clinical presentation and the findings from the synovial fluid analysis point towards acute gout.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Key Findings:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Acute Pain and Swelling of the Left Great Toe:</span></strong><span style=\"font-size:12.0pt\"> This is characteristic of acute gout, especially involving the first metatarsophalangeal (MTP) joint.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">No History of Trauma:</span></strong><span style=\"font-size:12.0pt\"> This excludes traumatic causes of joint pain.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Synovial Fluid Analysis Shows Raised Leukocytes:</span></strong><span style=\"font-size:12.0pt\"> Indicates an inflammatory arthritis.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Normal Serum Uric Acid Levels:</span></strong><span style=\"font-size:12.0pt\"> In 30-40% of acute gout cases, serum uric acid levels can be normal due to the uric acid being sequestered in the joint rather than in the bloodstream.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Acute Gout&nbsp;</span></strong><span style=\"font-size:12.0pt\">is a form of inflammatory arthritis caused by the deposition of monosodium urate crystals in joints, leading to intense pain and swelling. The first MTP joint is the most commonly affected site. Acute gout can present with normal serum uric acid levels, particularly during an acute attack, due to the uric acid being sequestered in the joint.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Diagnosis Confirmation:</span></strong><span style=\"font-size:12.0pt\"> The diagnosis of gout is confirmed by joint aspiration and identification of negatively birefringent needle-shaped crystals under polarized light microscopy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Pseudogout:</span></strong><span style=\"font-size:12.0pt\"> This condition usually presents in <strong>elderly individuals</strong> and often involves the knee or wrist joints. The presence of <strong>chondrocalcinosis on X-ray</strong> and the involvement of joints like knee (MC), wrist or MCP joint (NOT first MTP joint) makes pseudogout less likely in this case.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Reactive Arthritis:</span></strong><span style=\"font-size:12.0pt\"> This condition typically follows a gastrointestinal or genitourinary infection and involves multiple joints. There is no mention of such a history in this patient.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Septic Arthritis:</span></strong><span style=\"font-size:12.0pt\"> This condition is usually associated with more severe systemic symptoms like fever and a more aggressive clinical course. The patient&#39;s presentation does not match the typical features of septic arthritis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educaitonal Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute gout can present with normal serum uric acid levels, especially during an acute attack, and the involvement of the first metatarsophalangeal (MTP) joint is highly characteristic of this condition.</span></span></p>",
      "correct_choice_id": 81058,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47609,
      "choices": [
        {
          "id": 190047,
          "text": "<p><span style=\"font-size:12.0pt;\">Cardiac Tamponade</span></p>"
        },
        {
          "id": 190048,
          "text": "<p><span style=\"font-size:12.0pt;\">Status Asthmaticus</span></p>"
        },
        {
          "id": 190049,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypertrophic Cardiomyopathy</span></p>"
        },
        {
          "id": 190050,
          "text": "<p><span style=\"font-size:12.0pt;\">Tension Pneumothorax</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient had a drop in Systolic Blood Pressure of 15 mm Hg during inspiration. Which of the following is NOT associated with it?&nbsp;</span>(FMGE JANUARY 2024)</p>",
      "unique_key": "Q6591501",
      "question_audio": null,
      "question_video": null,
      "map_id": 34966090,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Hypertrophic Cardiomyopathy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A drop in systolic blood pressure of more than 10 mm Hg during inspiration is termed <strong>pulsus paradoxus.</strong> This phenomenon is seen in several conditions, including <strong>cardiac tamponade, status asthmaticus, and tension pneumothorax.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cardiac tamponade is a classic cause of pulsus paradoxus due to the restriction of ventricular filling during inspiration. Status asthmaticus and tension pneumothorax also cause significant intrathoracic pressure changes, leading to a similar hemodynamic effect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hypertrophic cardiomyopathy, on the other hand, is not associated with pulsus paradoxus. Instead, HCM can be associated with pulsus bisferiens, a double-peaked pulse.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Cardiac Tamponade:&nbsp;</strong>This is a well-known cause of pulsus paradoxus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Status Asthmaticus:&nbsp;</strong>This can cause pulsus paradoxus due to severe obstruction and changes in intrathoracic pressure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Tension Pneumothorax:&nbsp;</strong>This condition can also lead to pulsus paradoxus due to significant intrathoracic pressure changes.</span><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pulsus paradoxus, a significant drop in systolic blood pressure during inspiration, is seen in conditions like cardiac tamponade, status asthmaticus, and tension pneumothorax. It is not associated with hypertrophic cardiomyopathy, which can present with pulsus bisferiens instead.</span></p>",
      "correct_choice_id": 190049,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 84273,
      "choices": [
        {
          "id": 335672,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased fibrinogen, increased antithrombin III</span></p>"
        },
        {
          "id": 335673,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased fibrinogen-antithrombin III complexes</span></p>"
        },
        {
          "id": 335674,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased FDP, decreased PT, increased antithrombin III</span></p>"
        },
        {
          "id": 335675,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased FDP, prolonged PT, reduced platelets</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is a finding seen in Disseminated Intravascular Coagulation (DIC)? (NEET PG 2016)</span></p>",
      "unique_key": "Q2269555",
      "question_audio": null,
      "question_video": null,
      "map_id": 34966104,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><strong>Ans.&nbsp;D) Increased FDP, prolonged PT, reduced platelets.</strong></p><p>&nbsp;</p><p>DIC is characterized by widespread intravascular fibrin formation that leads to consumption of clotting factors and platelets. Laboratory evidence of DIC includes prolonged PT/aPTT, thrombocytopenia, and elevated levels of fibrin degradation products (FDPs). These findings reflect the underlying pathophysiology: excessive thrombin generation leads to fibrin formation and consumption of clotting factors (prolonging PT), platelet activation and consumption (reduced platelet count), and secondary fibrinolysis (increased FDPs) as the body attempts to break down the widespread clots.</p><p><strong>&nbsp;</strong></p><p><strong>Other Options:</strong></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><strong>Option A</strong>. <strong>Increased fibrinogen, increased antithrombin III</strong>:&nbsp; Because DIC typically features decreased fibrinogen due to consumption during widespread clotting. Plasma fibrinogen levels diminish acutely in severe cases of DIC. Similarly, antithrombin III levels are reduced in DIC (not increased), with high-grade DIC associated with antithrombin III activity &lt;60% of normal.</li><li><strong>Option B</strong>. <strong>Increased fibrinogen-antithrombin III complexes</strong>: While these complexes might form during coagulation, they are not a standard diagnostic marker for DIC. The diagnosis relies on more established markers like PT, platelet count, and FDPs.</li><li><strong>Option C.</strong> <strong>Increased FDP, decreased PT, increased antithrombin III</strong>: This is incorrect because in DIC, the PT is prolonged (not decreased) due to consumption of clotting factors. Additionally, antithrombin III levels are typically decreased in DIC, not increased.</li></ul><p>&nbsp;</p><p><strong>Educational Objective:</strong>&nbsp;</p><p>&nbsp;</p><p>The laboratory diagnosis of DIC involves a constellation of findings that reflect both excessive coagulation (prolonged PT, thrombocytopenia) and increased fibrinolysis (elevated FDPs) - representing the \"consumptive coagulopathy\" that defines this disorder.</p>",
      "correct_choice_id": 335675,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "InvestigationBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}